Comstock Inc. (LODE) - Q2 2025 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended June 30, 2025. Comstock Inc. is a technology and resource company focused on commercializing clean energy solutions, including solar panel recycling (Metals segment), renewable fuels (Bioleum subsidiary), and mining assets (Mining segment). The company operates as a non-accelerated filer and smaller reporting company. A 1-for-10 reverse stock split was effected on February 24, 2025, and all share data has been adjusted retrospectively.
Key Financial Metrics
| Metric | Q2 2025 (3 Months) | YTD 2025 (6 Months) | YTD 2024 (6 Months) |
|---|---|---|---|
| Revenue | $339,546 | $1,125,361 | $860,775 |
| Net Loss | $(7,826,943) | $(16,920,874) | $(15,570,592) |
| Net Loss Per Share (Basic/Diluted) | $(0.27) | $(0.63) | $(1.19) |
| Cash and Cash Equivalents | $18,587,742 | $18,587,742 | $114,304 |
| Total Assets | $148,216,957 | $148,216,957 | $91,309,881 |
| Total Liabilities | $56,355,363 | $56,355,363 | $31,540,796 |
| Working Capital | $7,632,100 | $7,632,100 | N/A |
| Debt (Net of Discounts) | $10,173,064 | $10,173,064 | $8,487,593 |
Note: YTD 2024 Net Loss attributable to Comstock Inc. was $(15,534,964).
Material Changes vs. Prior Period
- Liquidity Surge: Cash and cash equivalents increased by approximately $17.6 million from $954,271 at year-end 2024 to $18.59 million at June 30, 2025. This was driven primarily by financing activities, including a $20 million Series A investment in the Bioleum subsidiary and $10 million in debt issuances.
- Revenue Mix Shift: YTD revenue increased 31% to $1.13 million. This growth was driven by the Metals segment (decommissioning and recycling services), which offset a significant decline in the Mining segment due to the termination of the Mackay Mining Lease in late 2024.
- Operating Expenses: Selling, general, and administrative (SG&A) expenses increased significantly year-over-year due to higher employee costs, rent, and consulting fees. Research and development (R&D) expenses also rose, driven by renewable fuel projects and lease amendments.
- Non-Cash Gains/Losses: The company recognized a $200,000 gain on the sale of mineral rights and a $1.68 million gain from changes in the fair value of derivative instruments. Conversely, a $3.33 million loss was recorded on the conversion of debt to equity.
- Asset Base Expansion: Total assets grew by over $56 million, largely due to the acquisition of intangible assets (developed technologies) valued at over $20 million and the receipt of payment-in-kind assets from Marathon Petroleum.
Guidance, Outlook, and Risks
- Strategic Separation: Management is advancing the separation of Bioleum into a standalone, well-capitalized renewable fuels business. Bioleum has secured $20 million in Series A financing and is targeting a commercial demonstration facility in Oklahoma.
- Metals Segment Growth: Comstock Metals plans to scale its solar panel recycling operations, with the first industry-scale facility (100,000 tons/year capacity) expected to be commissioned in early 2026. Capital expenditures for this facility are estimated at $12 million.
- Asset Monetization: The company aims to monetize legacy real estate and non-strategic investments for over $50 million in 2025.
- Recent Financing (Subsequent Event): On August 12, 2025, the company announced a Confidentially Marketed Public Offering (CMPO) raising $30 million in gross proceeds. Proceeds will fund capital expenditures for the Metals facility, debt payoffs, and general corporate purposes.
- Risks: Key risks include the speculative nature of mineral exploration, the ability to secure additional capital for scaling operations, commodity price fluctuations, and the successful commercialization of unproven technologies. The company maintains a going concern basis but notes that future funding is required to sustain operations beyond the next 12 months without further capital raises.
Investor Verification Checklist
- Debt Conversion Terms: Verify the specific conversion prices and dilution impact of the Kips Bay Note conversions and the subsequent August 2025 payoff agreement.
- Bioleum Valuation: Confirm the valuation cap ($700 million) and terms of the Marathon Petroleum investment and the $20 million Series A financing.
- Derivative Liabilities: Review the fair value measurements of the Marathon SAFE Note ($12 million liability) and other derivatives, as these significantly impact net income and balance sheet volatility.
- Asset Sales Progress: Monitor the status of the $50 million target for monetizing non-strategic assets and the finalization of the Mackay mineral rights sale.
- Capital Expenditure Funding: Assess the sufficiency of the $30 million CMPO proceeds to cover the $12 million Metals facility build-out and other operational cash burn.